[시장보고서]펩타이드 의약품 API 수탁제조 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

펩타이드 의약품 API 수탁제조 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Peptide Therapeutics Contract API Manufacturing Market (Type of Synthesis Method Used and Scale of Operation ) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

상품코드 : 1552958

리서치사 : Transparency Market Research

발행일 : 2024년 07월

페이지 정보 : 영문 126 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,639,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 13,111,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,583,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

펩타이드 의약품 API 수탁제조 시장 - 조사 범위

TMR의 조사 보고서 "펩타이드 의약품 API 수탁제조 세계 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 있습니다. 이 보고서는 2024년을 기준 연도로, 2034년을 예측연도로 하여 2018년부터 2034년까지의 세계 펩타이드 의약품 API 수탁제조 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 펩타이드 의약품 API 수탁제조 시장의 연평균 성장률(CAGR %)을 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 펩타이드 의약품 API 수탁제조 시장을 이해하고자 했습니다.

시장 스냅샷
2023년 시장 규모	25억 달러
2034년 시장 규모	52억 달러
CAGR	6.8%

이 보고서는 세계 펩타이드 의약품 API 수탁제조 시장의 경쟁 환경을 조사하고 있습니다. 세계 펩타이드 의약품 API 수탁제조 시장에서 사업을 전개하는 주요 기업들을 파악하고, 각 기업들은 다양한 속성별로 프로파일링되어 있습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등 세계 펩타이드 의약품 API 수탁제조 시장의 주요 업체들의 프로필을 조사하여 정리했습니다.

시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
시장 점유율 분석 : 기업별(2023)
기업 개요
- Ambiopharm Inc
- Auspep
- Bachem Holding AG
- BCN Peptides
- Chinese Peptide Company
- CordenPharma
- CPC Scientific
- Creative Peptides
- CSBio
- Hybio Pharmaceutical
- Peptide Institute, Inc.
- PolyPeptide Group
- ScinoPharm
- Senn Chemicals AG

ksm

영문 목차

영문목차

Peptide Therapeutics Contract API Manufacturing Market - Scope of Report

TMR's report on the global peptide therapeutics contract API manufacturing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global peptide therapeutics contract API manufacturing market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peptide therapeutics contract API manufacturing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the peptide therapeutics contract API manufacturing market.

Market Snapshot
Market Value in 2023	US$ 2.5 Bn
Market Value in 2034	US$ 5.2 Bn
CAGR	6.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peptide therapeutics contract API manufacturing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peptide therapeutics contract API manufacturing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peptide therapeutics contract API manufacturing market.

The report delves into the competitive landscape of the global peptide therapeutics contract API manufacturing market. Key players operating in the global peptide therapeutics contract API manufacturing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peptide therapeutics contract API manufacturing market profiled in this report.

Key Questions Answered in Global peptide therapeutics contract API manufacturing Market Report:

What is the sales/revenue generated by peptide therapeutics contract API manufacturing across all regions during the forecast period?
What are the opportunities in the global peptide therapeutics contract API manufacturing market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Peptide Therapeutics Contract API Manufacturing Market - Research Objectives and Research Approach

The comprehensive report on the global peptide therapeutics contract API manufacturing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peptide therapeutics contract API manufacturing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peptide therapeutics contract API manufacturing market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Peptide Therapeutics Contract API Manufacturing Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, 2020-2034

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Scale of Operation

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Scale of Operation, 2020-2034
- 6.3.1. Preclinical/Clinical
- 6.3.2. Commercial
6.4. Market Attractiveness Analysis, by Scale of Operation

7. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Type of Synthesis Method Used

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
- 7.3.1. Non-chemical Synthesis Method
- 7.3.2. Chemical Synthesis Method
7.4. Market Attractiveness Analysis, by Type of Synthesis Method Used

8. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Enterprise Type

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Enterprise Type, 2020-2034
- 8.3.1. Large Enterprise
- 8.3.2. Small and Medium Enterprise
8.4. Market Attractiveness Analysis, by Enterprise Type

9. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Scale of Operation, 2020-2034
- 10.3.1. Preclinical/Clinical
- 10.3.2. Commercial
10.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
- 10.4.1. Non-chemical Synthesis Method
- 10.4.2. Chemical Synthesis Method
10.5. Market Value Forecast, by Enterprise Type, 2020-2034
- 10.5.1. Large Enterprise
- 10.5.2. Small and Medium Enterprise
10.6. Market Value Forecast, by Country, 2020-2034
- 10.6.1. U.S.
- 10.6.2. Canada
10.7. Market Attractiveness Analysis
- 10.7.1. By Scale of Operation
- 10.7.2. By Type of Synthesis Method Used
- 10.7.3. By Enterprise Type
- 10.7.4. By Country

11. Europe Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Scale of Operation, 2020-2034
- 11.3.1. Preclinical/Clinical
- 11.3.2. Commercial
11.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
- 11.4.1. Non-chemical Synthesis Method
- 11.4.2. Chemical Synthesis Method
11.5. Market Value Forecast, by Enterprise Type, 2020-2034
- 11.5.1. Large Enterprise
- 11.5.2. Small and Medium Enterprise
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 11.6.1. Germany
- 11.6.2. U.K.
- 11.6.3. France
- 11.6.4. Italy
- 11.6.5. Spain
- 11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
- 11.7.1. By Scale of Operation
- 11.7.2. By Type of Synthesis Method Used
- 11.7.3. By Enterprise Type
- 11.7.4. By Country/Sub-region

12. Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Scale of Operation, 2020-2034
- 12.3.1. Preclinical/Clinical
- 12.3.2. Commercial
12.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
- 12.4.1. Non-chemical Synthesis Method
- 12.4.2. Chemical Synthesis Method
12.5. Market Value Forecast, by Enterprise Type, 2020-2034
- 12.5.1. Large Enterprise
- 12.5.2. Small and Medium Enterprise
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.6.1. China
- 12.6.2. Japan
- 12.6.3. India
- 12.6.4. Australia & New Zealand
- 12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
- 12.7.1. By Scale of Operation
- 12.7.2. By Type of Synthesis Method Used
- 12.7.3. By Enterprise Type
- 12.7.4. By Country/Sub-region

13. Latin America Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Scale of Operation, 2020-2034
- 13.3.1. Preclinical/Clinical
- 13.3.2. Commercial
13.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
- 13.4.1. Non-chemical Synthesis Method
- 13.4.2. Chemical Synthesis Method
13.5. Market Value Forecast, by Enterprise Type, 2020-2034
- 13.5.1. Large Enterprise
- 13.5.2. Small and Medium Enterprise
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.6.1. Brazil
- 13.6.2. Mexico
- 13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
- 13.7.1. By Scale of Operation
- 13.7.2. By Type of Synthesis Method Used
- 13.7.3. By Enterprise Type
- 13.7.4. By Country/Sub-region

14. Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Scale of Operation, 2020-2034
- 14.3.1. Preclinical/Clinical
- 14.3.2. Commercial
14.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
- 14.4.1. Non-chemical Synthesis Method
- 14.4.2. Chemical Synthesis Method
14.5. Market Value Forecast, by Enterprise Type, 2020-2034
- 14.5.1. Large Enterprise
- 14.5.2. Small and Medium Enterprise
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.6.1. GCC Countries
- 14.6.2. South Africa
- 14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
- 14.7.1. By Scale of Operation
- 14.7.2. By Type of Synthesis Method Used
- 14.7.3. By Enterprise Type
- 14.7.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
- 15.3.1. Ambiopharm Inc
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. SWOT Analysis
  - 15.3.1.4. Financial Overview
  - 15.3.1.5. Strategic Overview
- 15.3.2. Auspep
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. SWOT Analysis
  - 15.3.2.4. Financial Overview
  - 15.3.2.5. Strategic Overview
- 15.3.3. Bachem Holding AG
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. SWOT Analysis
  - 15.3.3.4. Financial Overview
  - 15.3.3.5. Strategic Overview
- 15.3.4. BCN Peptides
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. SWOT Analysis
  - 15.3.4.4. Financial Overview
  - 15.3.4.5. Strategic Overview
- 15.3.5. Chinese Peptide Company
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. SWOT Analysis
  - 15.3.5.4. Financial Overview
  - 15.3.5.5. Strategic Overview
- 15.3.6. CordenPharma
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. SWOT Analysis
  - 15.3.6.4. Financial Overview
  - 15.3.6.5. Strategic Overview
- 15.3.7. CPC Scientific
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. SWOT Analysis
  - 15.3.7.4. Financial Overview
  - 15.3.7.5. Strategic Overview
- 15.3.8. Creative Peptides
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. SWOT Analysis
  - 15.3.8.4. Financial Overview
  - 15.3.8.5. Strategic Overview
- 15.3.9. CSBio
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. SWOT Analysis
  - 15.3.9.4. Financial Overview
  - 15.3.9.5. Strategic Overview
- 15.3.10. Hybio Pharmaceutical
  - 15.3.10.1. Company Overview
  - 15.3.10.2. Product Portfolio
  - 15.3.10.3. SWOT Analysis
  - 15.3.10.4. Financial Overview
  - 15.3.10.5. Strategic Overview
- 15.3.11. Peptide Institute, Inc.
  - 15.3.11.1. Company Overview
  - 15.3.11.2. Product Portfolio
  - 15.3.11.3. SWOT Analysis
  - 15.3.11.4. Financial Overview
  - 15.3.11.5. Strategic Overview
- 15.3.12. PolyPeptide Group
  - 15.3.12.1. Company Overview
  - 15.3.12.2. Product Portfolio
  - 15.3.12.3. SWOT Analysis
  - 15.3.12.4. Financial Overview
  - 15.3.12.5. Strategic Overview
- 15.3.13. ScinoPharm
  - 15.3.13.1. Company Overview
  - 15.3.13.2. Product Portfolio
  - 15.3.13.3. SWOT Analysis
  - 15.3.13.4. Financial Overview
  - 15.3.13.5. Strategic Overview
- 15.3.14. Senn Chemicals AG
  - 15.3.14.1. Company Overview
  - 15.3.14.2. Product Portfolio
  - 15.3.14.3. SWOT Analysis
  - 15.3.14.4. Financial Overview
  - 15.3.14.5. Strategic Overview

한글목차

펩타이드 의약품 API 수탁제조 시장 - 조사 범위

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계의 시장 분석과 예측 : 사업 규모별

제7장 세계의 시장 분석과 예측 : 합성법 유형별

제8장 세계의 시장 분석과 예측 : 기업 유형별

제9장 세계의 시장 분석과 예측 : 지역별

제10장 북미의 시장 분석과 예측

제11장 유럽의 시장 분석과 예측

제12장 아시아태평양의 시장 분석과 예측

제13장 라틴아메리카의 시장 분석과 예측

제14장 중동 및 아프리카의 시장 분석과 예측

제15장 경쟁 상황